Skip to main content
. 2019 Mar 22;17(5):4013–4022. doi: 10.3892/etm.2019.7428

Figure 4.

Figure 4.

Testosterone and insulin levels following induction of PCOS and at the end of the study. (A) Testosterone levels. &P<0.001 compared with study groups (at the 21st day); *P<0.001 compared with the PCOS control group (at the end of the study); #P=0.042 compared with the Metformin group (at the end of the study); (B) Insulin levels. &P<0.05 compared with study groups (at the 21st day); #P<0.001 compared with the PCOS control group (at the end of the study); *P=0.008 compared with the PCOS control group (at the end of the study); PCOS, polycystic ovary syndrome; PDE4i, phosphodiesterase 4 inhibitor.